

FOLLOWUS
Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
* E-mail: beijingzhangyushi@126.com
Received:08 January 2020,
Published Online:30 September 2020,
Published:30 September 2020
Scan QR Code
Wang Zhan, Wang Xu, Wang Wenda, et al. Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Predicting Prognosis of Surgically Resectable Urinary Cancers: Systematic Review and Meta-Analysis[J]. Chinese medical sciences journal, 2020, 35(3): 262-271.
Wang Zhan, Wang Xu, Wang Wenda, et al. Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Predicting Prognosis of Surgically Resectable Urinary Cancers: Systematic Review and Meta-Analysis[J]. Chinese medical sciences journal, 2020, 35(3): 262-271. DOI: 10.24920/003668.
目的
术前中性粒细胞与淋巴细胞比值(NLR)与多种恶性肿瘤的预后密切相关
但是
NLR对可切除泌尿系肿瘤预后的影响尚不确定。因此
此系统综述和荟萃分析旨在探讨术前NLR在预测可切除泌尿系肿瘤预后方面的价值。
方法
我们通过检索Embase、PubMed/MEDLINE和Cochrane数据库
依据纳入和排除标准筛选文献
最终纳入25项研究
其中包括15950例受试对象。采用风险比(
HR
s)及其95%可信区间(
CI
s)评估术前NLR与可切除泌尿系肿瘤患者的总生存期(OS)及肿瘤特异性生存期(CSS)的关系。
结果
结果表明对于患有可切除泌尿系恶性肿瘤的患者
术前NLR能预测其预后。NLR越高
患者的OS(
HR
=1.40
95%
CI
:1.26~1.54
P
<
0.001)和CSS越短(
HR
=1.43
95%
CI
:1.27~1.59
P
<
0.001)。此外
不论患者种族或术前NLR阈值高低
术前NLR升高均能提示肾细胞癌(OS:
HR
=2.06
95%
CI
=1.54~2.76
P
=0.131;CSS:
HR
=2.46
95%
CI
=1.46~4.16
P
=0.178)、上尿路上皮癌(OS:
HR
=1.91
95%
CI
=1.50~2.42
P
=0.616;CSS:
HR
=1.84
95%
CI
=1.41~2.39
P
=0.001)、膀胱癌(OS:
HR
=1.09
95%
CI
=1.02~1.17
P
<
0.001;CSS:
HR
=1.05
95%
CI
=1.01~1.09
P
=0.163)和前列腺癌(OS:
HR
=1.69
95%
CI
=1.19~2.41
P
=0.714)预后较差。
结论
术前NLR升高能够作为预测泌尿系可切除恶性肿瘤不良预后的指标
包括肾癌、膀胱癌、前列腺癌和上尿路上皮癌。
Objective
Accumulated evidence has suggested that there is a close association between preoperative neutrophil-to-lymphocyte ratio (NLR) and prognosis of various malignant tumors. However
the relationship between NLR and surgically resectable urinary cancers remains contradictory. Therefore
we performed this systematic review and meta-analysis to explore whether preoperative NLR could predict the prognosis of surgically resectable urinary cancers.
Methods
After searching the Embase
PubMed/MEDLINE and Cochrane databases and screening the articles
we finally included 25 studies involving 15950 patients. Hazard ratios (
HR
s) and their 95% confidence intervals (
CI
s) were extracted to assess the association between preoperative NLR and the overall survival (OS) and cancer-specific survival (CSS) of surgically resectable urinary cancers.
Results
The pooled results revealed that an elevated preoperative NLR could predict a worse OS (
HR
=1.40
95%
CI
: 1.26-1.54
P
<
0.001) and CSS (
HR
=1.43
95%
CI
: 1.27-1.59
P
<
0.001) in urinary cancers. In addition
our analyses also suggested that high preoperative NLR was associated with worse prognosis in renal cell carcinoma (OS:
HR
=2.06
95%
CI
: 1.54-2.76
P
=0.131; CSS:
HR
=2.46
95%
CI
: 1.46-4.16
P
=0.178)
upper tract urothelial carcinoma (OS:
HR
=1.91
95%
CI
: 1.50-2.42
P
=0.616; CSS:
HR
=1.84
95%
CI
: 1.41-2.39
P
=0.001)
bladder cancer (OS:
HR
=1.09
95%
CI
: 1.02-1.17
P
<
0.001; CSS:
HR
=1.05
95%
CI
: 1.01-1.09
P
=0.163) and prostate cancer (OS:
HR
=1.69
95%
CI
: 1.19-2.41
P
=0.714). Regardless of the participants’ race or the cutoff value of the preoperative NLR
the results remained valid.
Conclusion
Elevated preoperative NLR could predict a worse prognosis in surgically resectable urinary cancers
namely
renal cell carcinoma
bladder cancer
prostate cancer and upper tract urothelial carcinoma.
Siegel RL , Miller KD , Jemal A . Cancer statistics, 2019 . CA Cancer J Clin 2019 ; 69 ( 1 ): 7 - 34 . doi: 10.3322/caac.21551 10.3322/caac.21551 . DOI: 10.3322/caac.21551 http://doi.org/10.3322/caac.21551 https://www.ncbi.nlm.nih.gov/pubmed/30620402 https://www.ncbi.nlm.nih.gov/pubmed/30620402
Widz D , Mitura P , Buraczynski P , et al . Preoperative neutrophil-lymphocyte ratio as a predictor of overall survival in patients with localized renal cell carcinoma . Urol J 2020 ; 17 ( 1 ): 30 - 5 . doi: 10.22037/uj.v0i0.4541 10.22037/uj.v0i0.4541 . DOI: 10.22037/uj.v0i0.4541 http://doi.org/10.22037/uj.v0i0.4541 https://www.ncbi.nlm.nih.gov/pubmed/31087321 https://www.ncbi.nlm.nih.gov/pubmed/31087321
Jang WS , Cho KS , Kim KH , et al . Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy in localized prostate cancer . Prostate Cancer Prostatic Dis 2016 ; 19 ( 3 ): 298 - 304 . doi: 10.1038/pcan.2016.20 10.1038/pcan.2016.20 . DOI: 10.1038/pcan.2016.20 http://doi.org/10.1038/pcan.2016.20 https://www.ncbi.nlm.nih.gov/pubmed/27349499 https://www.ncbi.nlm.nih.gov/pubmed/27349499
Kang M , Jeong CW , Kwak C , et al . Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor . Oncotarget 2017 ; 8 ( 8 ): 12891 - 901 . doi: 10.18632/oncotarget.14179 10.18632/oncotarget.14179 . https://www.ncbi.nlm.nih.gov/pubmed/28039452 https://www.ncbi.nlm.nih.gov/pubmed/28039452
Chen Z , Wang K , Lu H , et al . Systemic inflammation response index predicts prognosis in patients with clear cell renal cell carcinoma: a propensity score-matched analysis . Cancer Manag Res 2019 ; 11 : 909 - 19 . doi: 10.2147/CMAR.S186976 10.2147/CMAR.S186976 . https://www.ncbi.nlm.nih.gov/pubmed/30697081 https://www.ncbi.nlm.nih.gov/pubmed/30697081
Vartolomei MD , Ferro M , Cantiello F , et al . Validation of neutrophil-to-lymphocyte ratio in a multi-institutional cohort of patients with T1G3 non-muscle-invasive bladder cancer . Clin Genitourin Cancer 2018 ; 16 ( 6 ): 445 - 52 . doi: 10.1016/j.clgc.2018.07.003 10.1016/j.clgc.2018.07.003 . DOI: 10.1016/j.clgc.2018.07.003 http://doi.org/10.1016/j.clgc.2018.07.003 https://www.ncbi.nlm.nih.gov/pubmed/30077463 https://www.ncbi.nlm.nih.gov/pubmed/30077463
Tan P , Xu H , Liu L , et al . The prognostic value of preoperative neutrophil-to-lymphocyte ratio in patients with upper tract urothelial carcinoma . Clin Chim Acta 2018 ; 485 : 26 - 32 . doi: 10.1016/j.cca.2018.06.019 10.1016/j.cca.2018.06.019 . https://www.ncbi.nlm.nih.gov/pubmed/29908941 https://www.ncbi.nlm.nih.gov/pubmed/29908941
Sun Z , Ju Y , Han F , et al . Clinical implications of pretreatment inflammatory biomarkers as independent prognostic indicators in prostate cancer . J Clin Lab Anal 2018 ; 32 ( 3 ): e22277 . doi: 10.1002/jcla.22277 10.1002/jcla.22277 . DOI: 10.1002/jcla.2018.32.issue-3 http://doi.org/10.1002/jcla.2018.32.issue-3 http://doi.wiley.com/10.1002/jcla.2018.32.issue-3 http://doi.wiley.com/10.1002/jcla.2018.32.issue-3
Son S , Hwang EC , Jung SI , et al . Prognostic value of preoperative systemic inflammation markers in localized upper tract urothelial cell carcinoma: a large, multicenter cohort analysis . Minerva Urol Nefrol 2018 ; 70 ( 3 ): 300 - 9 . doi: 10.23736/s0393-2249.18.02914-4 10.23736/s0393-2249.18.02914-4 . DOI: 10.23736/S0393-2249.18.02914-4 http://doi.org/10.23736/S0393-2249.18.02914-4 https://www.ncbi.nlm.nih.gov/pubmed/29381018 https://www.ncbi.nlm.nih.gov/pubmed/29381018
Rajwa P , Życzkowski M , Paradysz A , et al . Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy . Eur Rev Med Pharmacol Sci 2018 ; 22 ( 10 ): 3027 - 37 . doi: 10.26355/eurrev_201805_15060 10.26355/eurrev_201805_15060 . DOI: 10.26355/eurrev_201805_15060 http://doi.org/10.26355/eurrev_201805_15060 https://www.ncbi.nlm.nih.gov/pubmed/29863247 https://www.ncbi.nlm.nih.gov/pubmed/29863247
Kohada Y , Hayashi T , Goto K , et al . Preoperative risk classification using neutrophil-lymphocyte ratio and hydronephrosis for upper tract urothelial carcinoma . Jpn J Clin Oncol 2018 ; 48 ( 9 ): 841 - 50 . doi: 10.1093/jjco/hyy084 10.1093/jjco/hyy084 . https://www.ncbi.nlm.nih.gov/pubmed/30085174 https://www.ncbi.nlm.nih.gov/pubmed/30085174
Agizamhan S , Qu F , Liu N , et al . Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients . BMC Urol 2018 ; 18 ( 1 ): 60 . doi: 10.1186/s12894-018-0374-z 10.1186/s12894-018-0374-z . DOI: 10.1186/s12894-018-0374-z http://doi.org/10.1186/s12894-018-0374-z https://www.ncbi.nlm.nih.gov/pubmed/29890986 https://www.ncbi.nlm.nih.gov/pubmed/29890986
Vartolomei MD , Mathieu R , Margulis V , et al . Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy . World J Urol 2017 ; 35 ( 1 ): 121 - 30 . doi: 10.1007/s00345-016-1848-9 10.1007/s00345-016-1848-9 . DOI: 10.1007/s00345-016-1848-9 http://doi.org/10.1007/s00345-016-1848-9 https://www.ncbi.nlm.nih.gov/pubmed/27209168 https://www.ncbi.nlm.nih.gov/pubmed/27209168
Tan YG , Eu E , Lau Kam On W , et al . Pretreatment neutrophil-to-lymphocyte ratio predicts worse survival outcomes and advanced tumor staging in patients undergoing radical cystectomy for bladder cancer . Asian J Urol 2017 ; 4 ( 4 ): 239 - 46 . doi: 10.1016/j.ajur.2017.01.004 10.1016/j.ajur.2017.01.004 . DOI: 10.1016/j.ajur.2017.01.004 http://doi.org/10.1016/j.ajur.2017.01.004 https://www.ncbi.nlm.nih.gov/pubmed/29387556 https://www.ncbi.nlm.nih.gov/pubmed/29387556
Hu H , Yao X , Xie X , et al . Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients . World J Urol 2017 ; 35 ( 2 ): 261 - 70 . doi: 10.1007/s00345-016-1864-9 10.1007/s00345-016-1864-9 . DOI: 10.1007/s00345-016-1864-9 http://doi.org/10.1007/s00345-016-1864-9 https://www.ncbi.nlm.nih.gov/pubmed/27255479 https://www.ncbi.nlm.nih.gov/pubmed/27255479
Cao ZP , Guan B , Zhao GZ , et al . Validation of the pretreatment neutrophil-to-lymphocyte ratio as a prognostic factor in a large cohort of Chinese patients with upper tract urothelial carcinoma . Chin Med J (Engl) 2017 ; 130 ( 17 ): 2063 - 8 . doi: 10.4103/0366-6999.213414 10.4103/0366-6999.213414 .
Gu L , Ma X , Li H , et al . Prognostic value of preoperative inflammatory response biomarkers in patients with sarcomatoid renal cell carcinoma and the establishment of a nomogram . Sci Rep 2016 ; 6 : 23846 . doi: 10.1038/srep23846 10.1038/srep23846 . DOI: 10.1038/srep23846 http://doi.org/10.1038/srep23846 https://www.ncbi.nlm.nih.gov/pubmed/27035802 https://www.ncbi.nlm.nih.gov/pubmed/27035802
Cheng YC , Huang CN , Wu WJ , et al . The prognostic significance of inflammation-associated blood cell markers in patients with upper tract urothelial carcinoma . Ann Surg Oncol 2016 ; 23 ( 1 ): 343 - 51 . doi: 10.1245/s10434-015-4781-z 10.1245/s10434-015-4781-z . DOI: 10.1245/s10434-015-4781-z http://doi.org/10.1245/s10434-015-4781-z https://www.ncbi.nlm.nih.gov/pubmed/26242371 https://www.ncbi.nlm.nih.gov/pubmed/26242371
Byun SS , Hwang EC , Kang SH , et al . Prognostic significance of preoperative neutrophil-to-Lymphocyte ratio in nonmetastatic renal cell carcinoma: a large, multicenter cohort analysis . Biomed Res Int 2016 ; 2016 : 5634148 . doi: 10.1155/2016/5634148 10.1155/2016/5634148 . DOI: 10.1155/2016/5634148 http://doi.org/10.1155/2016/5634148 https://www.ncbi.nlm.nih.gov/pubmed/27891517 https://www.ncbi.nlm.nih.gov/pubmed/27891517
Wen RM , Zhang YJ , Ma S , et al . Preoperative neutrophil to lymphocyte ratio as a prognostic factor in patients with non-metastatic renal cell carcinoma . Asian Pac J Cancer Prev 2015 ; 16 ( 9 ): 3703 - 8 . doi: 10.7314/apjcp.2015.16.9.3703 10.7314/apjcp.2015.16.9.3703 . https://www.ncbi.nlm.nih.gov/pubmed/25987025 https://www.ncbi.nlm.nih.gov/pubmed/25987025
Tanaka N , Kikuchi E , Kanao K , et al . A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy . Ann Surg Oncol 2014 ; 21 ( 12 ): 4041 - 8 . doi: 10.1245/s10434-014-3830-3 10.1245/s10434-014-3830-3 . https://www.ncbi.nlm.nih.gov/pubmed/24912614 https://www.ncbi.nlm.nih.gov/pubmed/24912614
Luo HL , Chen YT , Chuang YC , et al . Subclassification of upper urinary tract urothelial carcinoma by the neutrophil-to-lymphocyte ratio (NLR) improves prediction of oncological outcome . BJU Int 2014 ; 113 ( 5b ): E144 - 9 . doi: 10.1111/bju.12582 10.1111/bju.12582 . DOI: 10.1111/bju.12582 http://doi.org/10.1111/bju.12582 https://www.ncbi.nlm.nih.gov/pubmed/24274691 https://www.ncbi.nlm.nih.gov/pubmed/24274691
Dalpiaz O , Ehrlich GC , Mannweiler S , et al . Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma . BJU Int 2014 ; 114 ( 3 ): 334 - 9 . doi: 10.1111/bju.12441 10.1111/bju.12441 . DOI: 10.1111/bju.12441 http://doi.org/10.1111/bju.12441 http://dx.doi.org/10.1111/bju.12441 http://dx.doi.org/10.1111/bju.12441
Pichler M , Hutterer GC , Stoeckigt C , et al . Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients . Br J Cancer 2013 ; 108 ( 4 ): 901 - 7 . doi: 10.1038/bjc.2013.28 10.1038/bjc.2013.28 . https://www.ncbi.nlm.nih.gov/pubmed/23385728 https://www.ncbi.nlm.nih.gov/pubmed/23385728
Azuma T , Matayoshi Y , Odani K , et al . Preoperative neutrophil-lymphocyte ratio as an independent prognostic marker for patients with upper urinary tract urothelial carcinoma . Clin Genitourin Cancer 2013 ; 11 ( 3 ): 337 - 41 . doi: 10.1016/j.clgc.2013.04.003 10.1016/j.clgc.2013.04.003 . DOI: 10.1016/j.clgc.2013.04.003 http://doi.org/10.1016/j.clgc.2013.04.003 https://www.ncbi.nlm.nih.gov/pubmed/23665132 https://www.ncbi.nlm.nih.gov/pubmed/23665132
Viers BR , Boorjian SA , Frank I , et al . Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy . Eur Urol 2014 ; 66 ( 6 ): 1157 - 64 . doi: 10.1016/j.eururo.2014.02.042 10.1016/j.eururo.2014.02.042 . DOI: 10.1016/j.eururo.2014.02.042 http://doi.org/10.1016/j.eururo.2014.02.042 http://dx.doi.org/10.1016/j.eururo.2014.02.042 http://dx.doi.org/10.1016/j.eururo.2014.02.042
Cho H , Hur HW , Kim SW , et al . Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment . Cancer Immunol Immunother 2009 ; 58 ( 1 ): 15 - 23 . doi: 10.1007/s00262-008-0516-3 10.1007/s00262-008-0516-3 . DOI: 10.1007/s00262-008-0516-3 http://doi.org/10.1007/s00262-008-0516-3 https://www.ncbi.nlm.nih.gov/pubmed/18414853 https://www.ncbi.nlm.nih.gov/pubmed/18414853
Fondevila C , Metges JP , Fuster J , et al . p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer . Br J Cancer 2004 ; 90 ( 1 ): 206 - 15 . doi: 10.1038/sj.bjc.6601455 10.1038/sj.bjc.6601455 . DOI: 10.1038/sj.bjc.6601455 http://doi.org/10.1038/sj.bjc.6601455 https://www.ncbi.nlm.nih.gov/pubmed/14710231 https://www.ncbi.nlm.nih.gov/pubmed/14710231
Hwang GI , Yoo CH , Sohn BH , et al . Predictive value of preoperative serum CEA, CA19-9 and CA125 levels for peritoneal metastasis in patients with gastric carcinoma . Cancer Res Treat 2004 ; 36 ( 3 ): 178 - 81 . doi: 10.4143/crt.2004.36.3.178 10.4143/crt.2004.36.3.178 . DOI: 10.4143/crt.2004.36.3.178 http://doi.org/10.4143/crt.2004.36.3.178 https://www.ncbi.nlm.nih.gov/pubmed/20396541 https://www.ncbi.nlm.nih.gov/pubmed/20396541
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621